Mangoceuticals, Inc.

NasdaqCM MGRX

Mangoceuticals, Inc. Total Non-Current Liabilities for the quarter ending September 30, 2024: USD 12.17 K

Mangoceuticals, Inc. Total Non-Current Liabilities is USD 12.17 K for the quarter ending September 30, 2024. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.

Key data

Date	Total Non-Current Liabilities	Shareholders' Equity	Other Liabilities	Total Liabilities

NasdaqCM: MGRX

Mangoceuticals, Inc.

CEO	Mr. Jacob D. Cohen
IPO Date	March 21, 2023
Location	United States
Headquarters	15110 North Dallas Parkway
Employees	3
Sector	Health Care
Industries Telehealth Pharmaceuticals

Description

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Key trends

Past 5 years